HYDROXOMIN

Post-LOE

hydroxocobalamin

Teva

ANDAINJECTIONINJECTABLE

Approved

May 1981

Lifecycle

Post-LOE

Competitive Pressure

30/100

Data completeness

3/8 — Basic

HYDROXOMIN (hydroxocobalamin) by Teva is poison. Approved for known, suspected cyanide poisoning. First approved in 1981.

Drug data last refreshed 18h ago

Mechanism of Action

poison. In the absence of rapid and adequate treatment, exposure to a high dose of cyanide can result in death within minutes due to the inhibition of cytochrome oxidase resulting in arrest of cellular respiration. Specifically, cyanide binds rapidly with cytochrome a3, a component of the…

Indications (2)

known

Worked on HYDROXOMIN at Teva? Share your interview experience or compensation data (+7 days Pro)

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.